Skip to main content
NNVC logo

NanoViricides, Inc.

NNVCNYSEAMERICANHealthcareBiotechnology

$1.38Today:- (-)1Y −8.67%

As of Oct 16, 2026 close

Market cap
$27.66M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.85$2.23
Volume (live)
-
Avg. volume (3M)
531.83K

NanoViricides (NNVC) Income Statement

In fiscal 2026 (fiscal year ended Jun 30, 2026), NanoViricides posted a net loss of $8.22M, compared with a net loss of $9.47M a year earlier.

NanoViricides Income Statement Analysis

Values in trillions USD

Scroll to see more
NanoViricides, Inc. income statement - Annual data in trillions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.000.000.000.00
Cost of Revenue0.000.000.000.000.000.000.000.000.000.00
Gross Profit0.000.000.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development4.710.000.000.000.000.000.000.000.000.00
Selling, General & Administrative3.600.000.000.000.000.000.000.000.000.00
Operating Expenses0.000.000.000.000.000.000.000.000.000.00
Operating Income0.000.000.000.000.000.000.000.000.000.00
Other Income/Expense
Interest Income0.000.000.000.000.000.000.000.000.000.00
Interest Expense0.000.000.000.000.000.000.000.000.000.00
Other Income/Expense0.000.000.000.000.000.000.000.000.000.00
Income
Income Before Tax0.000.000.000.000.000.000.000.000.000.00
Income Tax Expense0.000.000.000.000.000.000.000.000.000.00
Net Income0.000.000.000.000.000.000.000.000.000.00
Net Income - Continuous Operations0.000.000.000.000.000.000.000.000.000.00
Net Income - Discontinued Operations----------
EBITDA0.000.000.000.000.000.000.000.000.000.00
EBIT0.000.000.000.000.000.00----
Depreciation & Amortization0.000.000.000.000.000.000.000.000.000.00
Earnings Per Share
Basic EPS--1.00-1.00-1.00-1.00-1.00-2.00-2.00-3.00-3.00
Diluted EPS--1.00-1.00-1.00-1.00-1.00-2.00-2.00-3.00-3.00
Basic Shares Outstanding0.000.000.000.000.000.000.000.000.000.00
Diluted Shares Outstanding0.000.000.000.000.000.000.000.000.000.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NanoViricides Financial Statements

Is NanoViricides profitable?

No. NanoViricides reported a net loss of $8.22M in fiscal 2026. In fiscal 2025 it lost $9.47M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition